Abstract Objective: The objective of this study was to summarise data about endovascular stent-graft placement for patients with type B aortic dissection (type B-AD) in China. Methods: All published series in Chinese on endovascular stent-graft placement for type B-AD from 1999 through 2008 were identified. Thirty-five studies, involving a total of 1498 patients, were included in this review. Results: Procedure success was reported in 89.4 AE 1.7% of the patients. Overall complications were reported in 16.6 AE 1.2% of the patients. Major complications were reported in 1.7 AE 0.2%, with neurological complications in 0.5 AE 0.1%. In-hospital mortality was 2.0 AE 0.4%. The mean follow-up was 24.0 AE 16.1 months. Conclusion: Endovascular stent-graft placement is technically feasible with high procedure success and relatively low complication rate in selected patient groups with type B-AD. Both short-and mid-term outcomes appear to be favourable. ª
Successful stent grafting of patients with acute type B aortic dissection (B-AD) was first reported by Dake and colleagues 1 in 1999; Nienaber and colleagues 2 simultaneously reported their results in patients with sub-acute and chronic type B-AD. Eggebrecht et al. 3 performed a meta-analysis of stenting for aortic dissections with descending tears and showed a procedure success in 98.2%, stroke in 1.9% and paraplegia in 0.8% of the patients. Wang et al. 4 and Jing et al. 5 independently published the preliminary experience of endovascular stent-graft placement for type B-AD patients in China in 1999. Later, many studies have been published in Chinese-language publications. This article summarises all the data currently available about endovascular stent-graft placement for patients with type B-AD in China.
Materials and Methods

Data sources
With the search phrases 'aortic dissection' and 'stent graft' or 'endovascular', a comprehensive search of the Chinese-language medical literature between January 1999 and January 2008 was performed using the China National Knowledge Infrastructure database to identify all studies on endovascular stent-graft treatment for patients with type B-AD. A multistage assessment was used to include the qualified articles. At the first stage, only abstracts were reviewed. Only the articles focussing on endovascular stentgraft placement for patients (n ! 10) with type B-AD were included for data extraction. At the second stage, the full articles were reviewed; only the articles with sufficient data (!40% of pre-defined variables) and follow-up longer than
Definitions
Aortic dissection (AD) was classified according to the Stanford classification. It was considered acute if occurring within the first 14 days from onset of symptoms and chronic if it exceeded beyond that. The intervention indications for acute dissections were as follows: (1) persistent back/chest pain, (2) uncontrollable hypertension, (3) malperfusion syndrome, (4) rupture and (5) a maximal aortic diameter !5 cm. The indications for chronic dissections were: (1) psuedo-aneurysm with diameter !5 cm or rapid enlargement >5 mm per year and (2) acute symptoms. Complications were defined as major when life threatening or necessitating emergent management (e.g., stroke, access arterial damage) whereas minor ones were defined as those that may recover later without further aggressive treatment (e.g., infection of the access site). Procedure success was defined as complete coverage of the primary entry tear without a type I or III endoleak at the end of the procedure. Persistent endoleak was defined as one that still existed at the latest follow-up.
Data extraction
A standardised protocol for data extraction including 53 pre-defined variables regarding clinical characteristics, procedural data, in-hospital and follow-up data was introduced by Eggebrecht. 3 A modified standardised protocol including 47 pre-defined variables (six variables were deleted from the standardised protocol because only a few articles had mentioned them) was used to analyse each article in this review. Extraction of data was performed independently by the authors. Mutual consensus was achieved by further discussion when discrepancies occurred. Unspecified information was classified as not available (n.a); thus the number of patients (denominator) varied with the specific variables. For the studies without the required data for survival analysis, we managed to contact the corresponding authors or the first authors for supplementary materials about survival outcome.
Statistical analysis
The number of events divided by the number of treated patients with available data was used to calculate the individual rates of events. In order to avoid potential underestimation of events owing to the differing patient numbers, a worst-case model was calculated for some variables with important clinical impact. This model assumes that all reported, but unspecified, events occurred in dissection patients and provides a worst case of the rates. Results were presented as mean AE 1 standard deviation or median and range. Two-sided chi-square test for categorical variables and two-sided Student's t-test for continuous variable were used to compare between patients with acute and chronic type B-AD. The Kaplane Meier non-parametric method was used to estimate the mortality, and compared using the log-rank test. A P-value <0.05 was considered statistically significant. Statistical software SPSS 13.0 was used for all the statistical analysis mentioned earlier.
Results
Studies overview
Thirty-five studies, involving a total of 1498 patients, were included in this study. For some variables only a small proportion of the data were available. General information of these studies was overviewed (Table 1 ).
Procedural and in-hospital data
Procedure success of 89.4 AE 1.7% was achieved. Emergent surgical conversion was required in 0.2 AE 0.1% of patients (Table 1) . In-hospital complications were reported in 15.2 AE 1.1% of patients (worst-case estimate: 14.5 AE 1.1%) ( Tables 2 and 3 ). Major complications were 0.8 AE 0.2% (worst-case estimate: 0.8 AE 0.1%), whereas minor complications were reported as 14.2 AE 1.1% (worst-case estimate: 13.5 AE 1.1%). Procedure-related complications were 1.3 AE 0.5%, with retrograde type A-AD 0.1 AE 0.03% and access complications 1.2 AE 0.5%. As shown in Table 2 , 1.1 stents were used per patient, with Talent (Medtronic, USA) as the most commonly used stent graft ( Table 4 ). The neurological complications were 0.3 AE 0.1% (worst-case estimate: 0.3 AE 0.1%); of these patients, 0.3 AE 0.1% suffered a stroke (worst-case estimate: 0.3 AE 0.1%). Paraplegia was not reported during hospitalization. Thirty of 1437 patients died during the in-hospital period, and the overall in-hospital mortality was 2.1 AE 0.4% (worst-case estimate: 2.0 AE 0.4%), with rupture of the dissection as the leading cause of death (Table 5) . Two additional deaths occurred within the 30-day period, yielding a 30-day mortality of 2.2 AE 0.4%.
Overstenting of aortic branches
Intentional overstenting of left subclavian artery (LSA) without re-vascularisation was conducted in 88 patients among 1166 patients whose data were available (7.5%). Most of these patients tolerated the procedure well, except for three patients: one death each due to brain stem ischaemia (1.1%) and cerebral infarction (1.1%) and another suffered from mild left subclavian steal syndrome (LSSS) (1.1%), another underwent transient left extremity a Some studies just provided the number of endoleaks without classification. Considering that the case of endoleak type II or IV is rare, it was assumed that all the endoleaks were type I or III. malperfusion which was released by heparin injection (1.1%), and one experienced mild weakness of the left upper extremity (1.1%). The overall percentage of patients who had a complication because of the intentional overstenting without re-vascularisation was 5.7% (5 of 88). Revascularisation of LSA prior to overstenting was carried out for 14 patients among 1166 patients (1.2%), consisting of left common carotid artery (LCCA)eLSA bypass for six patients, LCCAeleft vertebral artery bypass for four, right subclavian arteryeLSA bypass for two patients, and unknown method of bypass for two. RCCAeLCCAeLSA bypass prior to overstenting of LSA and LCCA was carried out for one patient. Incident overstenting of LSA and LCCA happened in one patient, which was managed by emergent ascending aortaeLCCAeLSA bypass. Intentional overstenting of celiac axis with prior abdominal aortaecommon hepatic arteryesuperior mesentery artery bypass was carried out for two patients. Incident overstenting of celiac axis was not reported. For all the cases with re-vascularisation of the overstenting aortic branches, no overstenting-related complications were reported.
Follow-up data
Fourteen studies, including 641 patients, provided the mean follow-up period of 24.0 AE 16.1 months. False lumen thrombosis was reported in 84.2 AE 1.6% of the patients (Table 6 ). In 0.5 AE 0.04% of the patients, post-discharge surgical conversion was needed. Post-discharge complications were reported in 3.1 AE 0.8% of the patients and postdischarge mortality was 0.8 AE 0.1%. Persistent endoleak occurred in 1.5 AE 0.3% of the patients, nine of which, according to the data available, were type I endoleaks. Stent migration was observed in 0.4 AE 0.2% of the patients. In the survival analysis, 225 patients with detailed survival data were included. The cumulative survival rates were 
Acute versus chronic dissection
Of the total 35 studies, 18 specified whether stent-graft placement was carried out for acute or chronic type B-AD (Table 7) . For the overall complications, major complications, minor complications, procedure-related complications, stroke, paraplegia or 30-day mortality, there was no significant difference between the acute and chronic groups.
Discussion
Although dramatic improvement in operative techniques, anesthesiological methods, and medical therapy has been made in recent years, type B-AD still remains a challenging problem for vascular surgeons. Endovascular stent-graft placement for type B-AD has achieved encouraging shortand mid-term outcomes widely. Our study summarised all the data on endovascular stent-graft placement for type B-AD currently available in China. The in-hospital mortality was 2.1 AE 0.4%. Because of incomparability of patients, these early mortality rates cannot be compared with the results of open surgery. Surgical mortality ranging from 6.1% to 14% have been reported in two largest cardiovascular centres in China. 41, 42 Neurological deficits are the most devastating complications of open repair for type B-AD. The International Registry of Acute Aortic Dissection investigators 43 reported neurological deficits in 23.2% of the patients treated by traditional surgery, with cerebrovascular accident in 9.0% and paraplegia in 4.5%, respectively. The paraplegia rates for endovascular treatment of aortic dissections were reported much lower as 0.8% in the EUROSTAR trial. 44 In our study, no paraplegia occurred during hospitalization and only one case happened occurred after discharge, yielding an overall morbidity of 0.1%. Considering that only 1.1 stents were used per patient, we mainly attribute the low risk of paraplegia to the short length of thoracic aorta covered, as well as avoidance of aortic cross-clamping and subsequent reperfusion. When sufficient sealing of the primary entry tear can be achieved, using fewer stents to avoid long segment coverage can help to decrease the morbidity of paraplegia.
Insufficient length of the proximal landing zone remains a challenge for completely excluding the entry tear of the dissections. There is still a controversy on the safety of intentional overstenting the LSA. 45e47 Our data suggest that stent graft-induced occlusion of the LSA can be well tolerated by the majority of patients, with an acceptably low morbidity of neurological complications and mortality. In the condition of patent and dominant contralateral vertebral and a documented intact vertebrobasilar system, re-vascularisation of the LSA is not required prior to intentional coverage of the LSA.
Several studies have demonstrated higher in-hospital mortality and major complication rates for type B-AD treated with endovascular repair in the acute phase Figure 1 Kaplan-Meier estimate of overall survival.
compared with the chronic phase. 3, 48, 49 Less stable clinical status of the patients in the acute phase is considered as the most important determinant of worse survival. 49 The complicated conditions of rupture and malperfusion are also important predictors of early mortality. 50 These may explain the worse results in the acute group. In the initial period, considering the poor anti-hypertensive drug compliance and low rate of effective hypertension control in China, 51 a few of the stable uncomplicated patients were treated in the acute phase. This might explain the comparable outcomes in the acute group with the chronic group. However, following the current global consensus on acute type B-AD, 52 endovascular repair in China has lately been strictly reserved for cases complicated with rupture, malperfusion syndrome and intractable hypertension and pain. Intensive medical treatment for stable cases should be emphasised in the future.
Cost-effectiveness is another issue that is of concern. The most commonly used imported stents in China such as Talent (Medtronic, USA) and Zenith (Cook, USA) are quite expensive (about $15 000 per stent) and only a small proportion of patients in China can afford the cost. In the past 5 years, several homemade stents such as Hercules & Aegis (MicroPort, PRC) with a much lower price (about $7500 per stent) have emerged as an alternative with encouraging short-term results. 15, 18, 30, 36 More homemade stents will be used to increase the availability of stents for the relatively poor patients. However, meticulous studies are warranted to study the long-term complications and durability of the homemade stents.
As the morbidity of type B-AD is increasing in China, some demographics different from the European and American countries, such as a much younger age and sex ratio, have been observed. 53 This indicates that a multicentre randomised controlled tests to further study the endovascular repair for type B-AD in comparison to medical treatment or traditional surgery are required, and then to develop a practice guideline that is more adapted to Chinese patients in the coming years.
Nevertheless, limitations of our study should be pointed out. It is the selection of patients from observational series that may have a low representation. The relatively low percentage of studies with data available for some valuable parameters might further lower the representation and increase the selection bias. In some articles the definitions and primary data are ambiguous, which to some degree impair the statistical power and decrease the reliability of this study.
Conclusion
In conclusion, our study shows that stent-graft placement of type B-AD is feasible with high procedure success rate and acceptably low complication rates. Both early and midterm outcomes appear to be encouraging. Reasonably reducing the number of stent graft used can help to lower the morbidity of paraplegia. Intentional coverage of the LSA is safe for extending the short landing zone when contralateral blood distribution to the brain is sufficient.
Conflict of interest
None. 
